Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-61,100
Closed -$2.93M 4047
2019
Q3
$2.93M Buy
61,100
+50,000
+450% +$2.61M ﹤0.01% 2068
2019
Q2
$741K Buy
+11,100
New +$845K ﹤0.01% 2858
2019
Q1
Sell
-15,000
Closed -$1.86M 3741
2018
Q4
$1.86M Sell
15,000
-9,700
-39% -$1.6M ﹤0.01% 2219
2018
Q3
$6.03M Buy
+24,700
New +$5.71M 0.01% 1450

Other funds holding INGN

David Shaw's INGN Position: Q2 2026 in Review

David Shaw reduced its Inogen (INGN) stake by 20% in Q2 2026, selling an estimated $62.7K and leaving 37,171 shares worth $240K. The position accounts for ﹤0.01% of the portfolio, ranked #4498.

David Shaw first reported a position in INGN in Q1 2015 and has held it in 26 quarters since. The position peaked at $24.9M in Q4 2019. 128 funds tracked by Wall St. Rank hold INGN as of Q2 2026.

  • David Shaw held 37,171 shares of Inogen worth $240K as of Q2 2026.
  • David Shaw sold 9,472 Inogen shares in Q2 2026, an estimated $62.7K.
  • Inogen made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #4498 holding.
  • David Shaw first reported a position in Inogen in Q1 2015 and has held it in 26 quarters since.
  • David Shaw's Inogen position peaked at $24.9M in Q4 2019.
  • 128 funds tracked by Wall St. Rank held Inogen as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.